IMU 9.26% 5.9¢ imugene limited

Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-37

  1. 2,103 Posts.
    lightbulb Created with Sketch. 2335
    It's crazier that 9 people agree with your post!!!!

    Do you understand what is involved in bringing a vaccine to actual human clinical trials?

    Can you comprehend what a significant achievement it is that this company has dosed a patient with another of its cancer vaccines?

    Are you able to fathom the significance of this announcement? The amount of money, time and effort that has gone into developing PD1-vaxx over the past 5 years and obtaining all the prerequisite approvals to get to this point of actual human dosing??

    Just more brilliant progress from this company. With much, much more just around the corner.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.9¢
Change
0.005(9.26%)
Mkt cap ! $433.6M
Open High Low Value Volume
5.5¢ 5.9¢ 5.4¢ $1.489M 25.99M

Buyers (Bids)

No. Vol. Price($)
2 35252 5.9¢
 

Sellers (Offers)

Price($) Vol. No.
6.0¢ 1753430 24
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.